GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 151 filers reported holding GW PHARMACEUTICALS PLC in Q3 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $203,000 | +1.0% | 2,000 | 0.0% | 0.06% | -3.5% |
| Q2 2017 | $201,000 | +1446.2% | 2,000 | +1900.0% | 0.06% | +1325.0% |
| Q3 2016 | $13,000 | -7.1% | 100 | -50.0% | 0.00% | 0.0% |
| Q1 2016 | $14,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $14,000 | -22.2% | 200 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $18,000 | -25.0% | 200 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $24,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |